Urologic evaluation before treatment is indicated when baseline prostate specific antigen (PSA) is ≥4 ng/mL (3 ng/mL for those at increased risk of prostate cancer, such as African-Americans and men ...
Androgens can drive prostate cancer growth, thus providing the rationale for using deprivation of androgens as a first line of treatment for prostate cancer. Unfortunately, prostate cancer cells adapt ...
Aviva Bio is advancing AVA-291 (d3-T) as a differentiated testosterone in a broad development program addressing multiple ...
Prognostic Significance of NPM1 Mutations in the Absence of FLT3–Internal Tandem Duplication in Older Patients With Acute Myeloid Leukemia: A SWOG and UK National Cancer Research Institute/Medical ...
Testosterone is the quintessential male hormone (androgen), and it’s a busy one, helping to regulate intimate function, muscle mass, red blood cell count, mood, and more. But not all testosterone in ...
The evolution of a validated clinical syndrome from an initial recognition of a cluster of symptoms to the clear delineation of a defining set of biochemical, biobehavioral, and physical findings is a ...
Total testosterone represents the sum of free, or bioavailable, testosterone and a more sizeable proportion bound to sex hormone-binding globulin (SHBG) and albumin. Total testosterone readings may ...
What is androgen deprivation therapy? Alicia Morgans, M.D., MPH: Androgen deprivation therapy, sometimes called ADT or hormonal therapy, is a way of treating prostate cancer that is used pretty ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results